Refine by
Biomedical Scientific Articles & Analysis: Older
176 news found
CD BioGlyco, a leading provider in the field of glycoproteomics, has recently updated its Glycoprotein Quantification Service. This enhancement aims to offer more precise and comprehensive glycoprotein analysis, catering to the growing demands in the fields of biomedical research, disease biomarker discovery, and therapeutic development. Protein glycosylation, a major post-translational ...
With years of experience in the pharmaceutical and life science sectors, CD Bioparticles announces its advanced line of multiplex fluorescence particles designed to streamline complex biological assays in flow cytometry experiments. These particles exhibit low signal widths in the forward scatter, side scatter and fluorescence channels. Various surface modifications, channels and sizes are also ...
CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, is pleased to announce the launch of its new line of Circulatory System Tissue Microarrays to the scientific community. This new product line offers researchers a powerful tool to study a wide range of diseases affecting the heart, blood vessels, and spleen. CD BioSciences is ...
Amerigo Scientific, a distributor focused on providing critical products and services to biomedical and life science communities, aims to enhance cell culture results by providing researchers and laboratories with a variety of simple and high-performance 3D cell culture systems. ...
In the ever-evolving landscape of biomedical research and public health, CD Formulation has emerged as a crucial player, offering comprehensive antiserum preparation services. ...
Amerigo Scientific, a distributor focused on providing critical products and services to biomedical and life science communities, is proud to showcase its featured offering in cell-free protein expression supplies - the pEU vector set. ...
Amerigo Scientific, a distributor focused on providing critical products and services to biomedical and life science communities, is delighted to announce the launch of its featured product, the Hydrazide Gel Kit for high-yield protein purification. ...
Amerigo Scientific, as a distributor focused on providing critical products and services to biomedical and life science communities, recently rolled out their cutting-edge real-time PCR kits for Hepatitis A virus (HAV) research. ...
The Singapore Week of Innovation and Technology (SWITCH) brings together leaders, entrepreneurs, creators, accelerators and investors from the Global-Asia innovation ecosystem. Through the open exchange of new ideas, vibrant networks and a line-up of innovation-centric activities, SWITCH provides a global platform to catalyse meaningful collaboration between different fields and markets. ...
Amerigo Scientific, a distributor focused on providing critical products and services to biomedical and life science communities, unveils the addition of the reliable Daptomycin ReadyMade™ Solution to its growing portfolio of innovative products to power up spectrum and microbiology applications. ...
Creative BioMart, one of the world leading biotechnology companies serving science, recently updated its R-PEAPC Conjugated Proteins offerings to meet different research needs and applications. R-PE Labeled Proteins are labeled products generated by combining R-PE fluorescent dyes with proteins. R-PE labeled protein is non-toxic, odorless, and has high stability. And when the excitation ...
With the release of the game-changing XDC bioconjugation platform, BOC Sciences reaffirms its commitment to driving innovation and empowering researchers in their quest for breakthrough discoveries in biomedical science. "It is now all set to serve researchers' diverse bioconjugation needs," the spokesperson said to the scientists. ...
In a groundbreaking move to revolutionize the field of biomedical research, Alfa Chemistry recently announced the launch of its highly anticipated custom organs-on-chips service. ...
Amerigo Scientific, a distributor focused on providing critical products and services to biomedical and life science communities, recently cooperates with Life Science Group to distribute the Viral Transport Medium CDC Protocol. ...
Amerigo Scientific, a distributor focused on providing critical products and services to biomedical and life science communities, unveils 1Step RT PCR Kit for the scientific use of gene-expression analysis, transfection analysis, cDNA cloning, multiplex RT-PCR, etc. ...
Biolojic Design has assembled an impressive team of advisors including: Eugene Bauer, PhD, Former CMO and founder of Dermira, Former dean of Stanford Medical School Tim Garnett, MD, Former CMO, Eli Lilly John Hastewell, PhD, Former Head of Novartis Institute for Biomedical Research Biologics Center Michael Hayden, MD, PhD, Former CSO of Teva Pharmaceuticals, Killam ...
CytoRecovery, Inc., a leader in marker free technologies for the enrichment, sorting, and recovery of live cells, announced today that the National Science Foundation (NSF) has approved its application to receive a Phase II SBIR Research Grant. Titled “Bioelectrical Cell Enrichment, Sorting, and Recovery with On-Chip Sample Prep and Monitoring,” the grant will provide $952,558 in ...
Metabolomics, a division of Creative Proteomics, is dedicated to providing cutting-edge LC-MS-based metabolomics services for biomedical research institutions as well as biotechnological and pharmaceutical companies. Creative Proteomics Metabolomics announced the launch of the Gut Microbiota Metabolomics Service, aiming to detect the dynamic changes in enterobacterial metabolites and clearly ...
Protein Metrics Inc., a leading provider of biopharmaceutical and proteomics analysis software, announced today a new partnership to advance glycoproteomics and biotherapeutics tools and research Macquarie University’s Analytical Glycoimmunology Group and Protein Metrics Inc. today have launched a strategic partnership scheme to further advance glycoproteomics and biotherapeutics ...
Lumen Bioscience — a clinical stage biopharmaceutical company developing biologic drugs for highly prevalent diseases — announced today preliminary results from a Biomedical Advanced Research and Development Authority (BARDA)-supported effort to develop an intranasal formulation of its drug candidate, LMN-301. This drug, produced in spirulina, contains an antibody cocktail for ...